Tecnovax


Tecnovax is an animal-health biotechnology company focused on the research, development, manufacture and global commercialization of vaccines and immunotherapies for production and companion animals. The company operates GMP and BSL-3 qualified facilities, provides contract manufacturing and lyophilized injectable product development, conducts molecular quality-control and vaccine response studies, and supplies veterinary advisory and field diagnostic services. Tecnovax exports products and services to multiple countries and reports over one billion doses administered.

Industries

Biotechnology
Manufacturing
Pharmaceutical
Veterinary
Biotechnology Research

Nr. of Employees

medium (51-250)

Tecnovax


Products

Ruminant vaccine product line

Vaccine line for prevention of infectious diseases in ruminants, including multivalent formulations for reproductive, clostridial and respiratory diseases.

Equine vaccine product line

Vaccine line for prevention of infectious diseases in horses.

Canine and feline vaccine product line

Vaccine line for prevention of common infectious diseases in companion animals, including live-attenuated and lyophilized formulations for feline and canine pathogens.

Aquatic vaccine product line

Vaccine line directed to aquatic species (e.g., salmonids) designed to protect farmed fish against major infectious agents.


Services

Design, systematization and follow-up of integrated sanitary plans; training, sample collection, diagnostics and monitoring of circulating viruses and bacteria for farms and production units.

Expertise Areas

  • Vaccine development for animal health
  • Contract manufacturing (CMO) for biologicals
  • GMP and BSL-3 containment operations
  • Molecular quality control and diagnostics
  • Show More (4)

Key Technologies

  • Recombinant DNA technology
  • Cell culture production
  • Fermentation processes
  • Downstream molecular purification
  • Show More (7)

News & Updates

Article discussing comparative development of salmon industry and implications for aquaculture; published on Tecnovax site.

Article on reproductive diseases in cattle and measures to protect herd productivity.

Company perspective on the role of science and animal health in sustaining livestock production.

Company reports over one billion doses administered across five continents.

Exports and commercial presence reported in 24+ countries with regional subsidiaries.

Company operates GMP-certified plants qualified as biosafety level 3 and dedicated vivarium testing facilities.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.